article thumbnail

GE HealthCare wraps up purchase of Nihon Medi-Physics

AuntMinnie

GE HealthCare has purchased full ownership of Japanese radiopharmaceutical developer Nihon Medi-Physics (NMP) from Sumitomo Chemical. The deal, which was initially announced at RSNA 2024 , is expected to be neutral to GE HealthCare's adjusted earnings per share in the first year and accretive thereafter, according to the vendor.

article thumbnail

GE HealthCare to launch Flyrcado injection in U.S.

AuntMinnie

GE HealthCare plans to launch its Flyrcado (flurpiridaz F-18) injection in the U.S. GE HealthCare's launch coincides with the receipt of pass-through status by the Centers for Medicare & Medicaid Services (CMS), effectiveApril 1st. The company received approval from the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Radiopharmaceutical startup raises $56M in series A financing from GE HealthCare, Mayo Clinic

Radiology Business

Nucleus RadioPharma will use the money to establish manufacturing facilities—with one located in Rochester, Minnesota, near Mayo—and build new technology for distribution.

article thumbnail

GE HealthCare to launch Flyrcado injection in U.S.

AuntMinnie

GE HealthCare plans to launch its Flyrcado (flurpiridaz F-18) injection in the U.S. GE HealthCare's launch coincides with the receipt of pass-through status by the Centers for Medicare & Medicaid Services (CMS), effectiveApril 1st. The company received approval from the U.S.

article thumbnail

New guidelines cover theranostics for brain tumors

AuntMinnie

These SSTRs can be targeted both with gallium-68 (Ga-68) imaging agents and therapeutic lutetium-177 (Lu-177) radiopharmaceuticals using a so-called theranostics approach. healthcare setting, they wrote. In the U.S., The full article is available here.

article thumbnail

CMS Adjusts Nuclear Medicine Reimbursement Policy, Expanding Access to Life-Saving Scans

Imaging Technology

Under the new policy, CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630, removing financial barriers that have long hindered patient access to essential nuclear medicine diagnostic procedures. tim.hodson Thu, 11/07/2024 - 11:25 Nov. Your voices made a difference.”

article thumbnail

Italian research team shows the way on sustainability

AuntMinnie

Additionally, modalities like MRI, CT, bone scans, and PET-CT are significant contributors to greenhouse gas emissions, with radiology accounting for approximately 1% of global healthcare-related emissions. SPECT and low-dose CT scans could be added for areas with suspected radiopharmaceutical uptake. hours), followed by DL1 (0.37 0.05

Bone Scan 130